Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

03. Juni 2013 11:04 ET | Quelle: nContact, Inc.

Connecticut Cardiac Arrhythmia Center at Bridgeport Hospital Publishes Initial Outcomes on the Convergent Procedure for Persistent and Longstanding Persistent Atrial Fibrillation Patients

MORRISVILLE, N.C., June 3, 2013 (GLOBE NEWSWIRE) -- EP Lab Digest has published the second part of a series of single-center outcomes using the Convergent Procedure, an epicardial-endocardial ablation...
30. Mai 2013 11:13 ET | Quelle: nContact, Inc.

Newly Published Data Highlights & Reviews Convergent Procedure Outcomes for Persistent Atrial Fibrillation Patients

MORRISVILLE, N.C., May 30, 2013 (GLOBE NEWSWIRE) -- Arrhythmia and Electrophysiology Review has published single-center outcomes using the Convergent Procedure, an epicardial-endocardial ablation...
09. Mai 2013 08:00 ET | Quelle: nContact, Inc.

nContact to Initiate CONVERGE IDE Clinical Trial -- First Head-to-Head Study Comparing the Multidisciplinary Convergent Procedure to Endocardial Catheter Ablation for the Treatment of Symptomatic Persistent Atrial Fibrillation

MORRISVILLE, N.C., May 9, 2013 (GLOBE NEWSWIRE) -- nContact, Inc. today announced that it has received conditional approval for an Investigational Device Exemption (IDE) from the U.S. Food and Drug...

Vorherige Seite